Gentamicin. Clinical and pharmacological studies.
D000151:Acinetobacter Infections / Q000188:drug therapy; D001442:Bacteroides Infections / Q000188:drug therapy; D001660:Biliary Tract Diseases / Q000188:drug therapy; D002481:Cellulitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004754:Enterobacter / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D005839:Gentamicins / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007709:Klebsiella / Q000187:drug effects; D007710:Klebsiella Infections / Q000188:drug therapy; D008581:Meningitis / Q000188:drug therapy; D010031:Otitis / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012706:Serratia marcescens / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D014136:Tracheitis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D014946:Wound Infection / Q000188:drug therapy
D005839:Gentamicins